SLC7A11 and early-onset autosomal dominant Alzheimer disease: Gong et al. showed that curculigoside significantly restrained the progression of Alzheimer’s disease and ameliorated cognitive dysfunction by upregulating GPX4 and inhibiting the SLC7A11 pathway [31].